Provided by Tiger Trade Technology Pte. Ltd.

Connect Biopharma Holdings Ltd.

1.73
-0.3150-15.44%
Post-market: 1.740.0150+0.87%19:59 EDT
Volume:2.69M
Turnover:4.61M
Market Cap:108.61M
PE:-1.45
High:1.82
Open:1.79
Low:1.58
Close:2.04
52wk High:3.82
52wk Low:1.23
Shares:62.96M
Float Shares:21.07M
Volume Ratio:2.16
T/O Rate:12.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1933
EPS(LYR):-1.0000
ROE:-140.51%
ROA:-69.75%
PB:4.04
PE(LYR):-1.72

Loading ...

Connect Biopharma Holdings Ltd - Rademikibart Well Tolerated With Safety Comparable to Placebo

THOMSON REUTERS
·
Mar 30

Connect Biopharma Holdings Ltd - Rademikibart Well-Tolerated With No Serious or Severe Adverse Events

THOMSON REUTERS
·
Mar 30

Connect Biopharma Holdings Ltd - Recruitment Ongoing for Phase 2 Seabreeze Stat Studies; Topline Data Expected Mid-2026

THOMSON REUTERS
·
Mar 30

Connect Biopharma Holdings Ltd - Rademikibart 300 Mg Iv Push Produces Rapid Fev1 Improvement ≥200 Ml in Asthma and Copd

THOMSON REUTERS
·
Mar 30

Connect Biopharma Holdings Ltd expected to post a loss of CNY1.41 a share - Earnings Preview

Reuters
·
Mar 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 20

Connect Biopharma Director James Huang Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Connect Biopharma President David Leslie Szekeres files initial beneficial ownership statement

Reuters
·
Mar 17

Connect Biopharma CEO and Director Barry D Quart files initial beneficial ownership statement

Reuters
·
Mar 17

Connect Biopharma SVP of Finance Lisa Peraza files initial beneficial ownership statement

Reuters
·
Mar 17

Connect Biopharma Director Kleanthis Gabriel Xanthopoulos Files Initial Beneficial Ownership Statement

Reuters
·
Mar 17

Connect Biopharma director Karen J. Wilson files initial beneficial ownership statement

Reuters
·
Mar 17

Connect Biopharma files Form 3 initial beneficial ownership statement for Director James A. Schoeneck

Reuters
·
Mar 17

Connect Biopharma Director Jean I Liu Files Initial Beneficial Ownership Statement

Reuters
·
Mar 17